Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | genetic association 0.01 (overall 0.05) | 0.01 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 16 Parkinson's papers of 1,251 | 0.63 |
| pathways Reactome | 5 pathways; mostly energy | 0.60 |
No case: the score is under the bar. Receipt 4979
Sealed predictions
- SLC2A1 in dopamine neurons, braak-0.03 (p 0.946) → -0.88 (p 0.002)receipt 4987
Swarm cases
receipt 4987: SLC2A1 in dopamine neurons, braak
- power
- full sample -0.58 (p 0.011, n 18), 95% CI -0.83 to -0.16. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.58 (p 0.011, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.58 (p 0.011, n 18). not the mix.
- skeptic
- leave-one-out range -0.71 to -0.53, sign flips 0; without severely affected donors -0.58 (p 0.011, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SLC2A1 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts